Genomic Vision Raises €4M in its Series B Financing
By James Etheridge
Wednesday, July 30, 2008
BioWorld International Correspondent
PARIS - Genomic Vision, which is developing new diagnostic tools and therapeutics in the areas of cancer and acute genetic and viral diseases, completed a series B financing in which it raised €4 million (US$6.3 million).
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.